Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
The Wall Street Journal | Feb 23, 2022
Recent Posts
- Medicare Limits Coverage of Controversial Alzheimer’s Drug to Those in Clinical Trials
- For People With Down Syndrome, A Longer Life, But Under A Cloud
- More Lawmakers Ratchet Up Pressure on CMS to Overturn Aduhelm Coverage Proposal
- National Coverage Determination May Limit Access to AD Treatment
- Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
Experience our inspirational and groundbreaking videos and photos. Our children and self-advocates are beautiful AND brilliant!
Make sure your local Representatives are on the Congressional Down Syndrome Task Force.